Skip to content

To study the effect of cooling Talcum powder in human beings.

A Randomized, double blinded, Monocentric, Interventional, Prospective Comparative Clinical study to Evaluate Efficacy and Safety of a cooling talc in healthy participants - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074155
Enrollment
108
Registered
2024-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Cooling Talc- DRDC/2024/034: Approximately 3g to 5g of talcum powder will be applied uniformly on axilla, chest, neck and lumbar region after bath/wash. Procedure will be done once dail

Sponsors

Dabur Research & Development Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male/Female healthy participants between the age of 18 years to 60 years (both inclusive) with normal to excessive sweating. 2. Shaving 48 hours prior to visit. 3. Presenting healthy skin on test site. 4. Accepting not to use products with same end benefit, for 1 week prior to study and on day of study. 5. Having signed a Consent Form after being informed orally and in writing of all information concerning the study procedures and study objectives. 6. Ready to comply with the study specifications. 7. Willingness to avoid water contact activities (i.e.: swimming) or activity during the course of the study. 8. Cooperating, informed of the need and duration of the examinations

Exclusion criteria

Exclusion criteria: 1. Female who is pregnant by history or lactating women. 2. Participants having Hyperthyroidism based on history. 3. Participants working in environments having high temperatures. 4. Pre menopausal/ Peri menopausal women. 5. Participants on any systemic medical treatment which may interfere with the performance of the study treatment (presently or in the past 1 month). 6. Participant in an exclusion period or participating in any clinical trial within 30 days prior to screening. 3. Participant in an exclusion period or participating in any clinical trial within 30 days prior to screening.

Design outcomes

Primary

MeasureTime frame
Assessment of cooling and refreshing feeling/experience (cooling freshness) after application of Talcum powder and its duration (for which the feeling lasts â?? 12 hours) â?? through participant diary and interview with the consumer by the Investigator/Clinical Researcher.Timepoint: Day 1, Day 7, Day 15 (before application and immediately after application, 6 hours, 12 hours

Secondary

MeasureTime frame
1. Assessment of Sweat using Gravimetric assay. 2. Assessment of sweat using Axillary Sweating Daily Diary (ASDD) 3. Assessment of sweat control and number of hours of sweat control post application as experienced by the consumer through participant diary and interview. 4. Assessment of the duration of effect based on consumer experience (diary and interview by the Investigator) 5. Assessment of duration for which fragrance (time duration) on Day 1 post application of Product (before application and immediately after application, 6 hours, 12 hours). 6. Assessment of adverse events during product usage. Timepoint: Day 0, Day 7, Day 15 Day 0 (For Gravimetric Analysis)

Countries

India

Contacts

Public ContactDr Ruchi Srivastava

Clinical Aesthetics and Investigative Management Service Pvt. Ltd. (C.L.A.I.M.S.PVT.LTD.)

preetha@claimsclinical.com66758851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026